The DOI matches its Crossref record; 1,227 of the 1,227 references it cites were found in a registry or an index.
Dopamine, Immunity, and Disease
Open accessAbstract
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function, regulating many processes including reward, movement, and cognition. Dopamine also regulates critical functions in peripheral organs, such as blood pressure, renal activity, and intestinal motility. Beyond these functions, a growing body of evidence indicates that dopamine is an important immunoregulatory factor. Most types of immune cells express dopamine receptors and other dopaminergic proteins, and many immune cells take up, produce, store, and/or release dopamine, suggesting that dopaminergic immunomodulation is important for immune function. Targeting these pathways could be a promising avenue for the treatment of inflammation and disease, but despite increasing research in this area, data on the specific effects of dopamine on many immune cells and disease processes remain inconsistent and poorly understood. Therefore, this review integrates the current knowledge of the role of dopamine in immune cell function and inflammatory signaling across systems. We also discuss the current understanding of dopaminergic regulation of immune signaling in the CNS and peripheral tissues, highlighting the role of dopaminergic immunomodulation in diseases such as Parkinson's disease, several neuropsychiatric conditions, neurologic human immunodeficiency virus, inflammatory bowel disease, rheumatoid arthritis, and others. Careful consideration is given to the influence of experimental design on results, and we note a number of areas in need of further research. Overall, this review integrates our knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopaminergic regulation of immunity. SIGNIFICANCE STATEMENT: Canonically, dopamine is recognized as a neurotransmitter involved in the regulation of movement, cognition, and reward. However, dopamine also acts as an immune modulator in the central nervous system and periphery. This review comprehensively assesses the current knowledge of dopaminergic immunomodulation and the role of dopamine in disease pathogenesis at the cellular and tissue level. This will provide broad access to this information across fields, identify areas in need of further investigation, and drive the development of dopaminergic therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 801–1,000 of 1,227
Meredith, E. J., Holder, M. J., Rosén, A., Lee, A. D., Dyer, M. J. S., Barnes, N. M., & Gordon, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605993103 · Cited by 71
Ferrari, M., Cosentino, M., Marino, F., Bombelli, R., Rasini, E., Lecchini, S., & Frigo, G. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.004 · Cited by 71
Transcriptional Regulation of CYP2D6 Expression
Pan, X., Ning, M., & Jeong, H. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.072249 · Cited by 71
Exercise activates vagal induction of dopamine and attenuates systemic inflammation
Shimojo, G. L., Joseph, B., Shah, R., Consolim‐Colombo, F. M., Angelis, K. D., & Ulloa, L. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.10.005 · Cited by 71
Yokokura, M., Takebasashi, K., Takao, A., Nakaizumi, K., Yoshikawa, E., Futatsubashi, M., Suzuki, K., Nakamura, K., Yamasue, H., & Ouchi, Y. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0784-7 · Cited by 71
Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy
Landvogt, C., Buchholz, H., Bernedo, V., Schreckenberger, M., & Werhahn, K. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02569.x · Cited by 70
Dopamine Receptor Signaling Defects in Spontaneous Hypertension
José, P. A. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00351-7 · Cited by 70
Kuštrimović, N. Z., Rasini, E., Legnaro, M., Marino, F., & Cosentino, M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9541-5 · Cited by 70
MacEachern, S. J., Patel, B. A., Keenan, C. M., Dicay, M. S., Chapman, K., McCafferty, D., Savidge, T., Beck, P. L., MacNaughton, W. K., & Sharkey, K. A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.007 · Cited by 70
Dopamine receptors and hypertension
Banday, A. A., & Lokhandwala, M. F. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0051-9 · Cited by 70
The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Covino, D. A., Sabbatucci, M., & Fantuzzi, L. (2015) · Current Drug Targets · doi:10.2174/138945011701151217110917 · Cited by 70
Recent advances in understanding basophil‐mediated Th2 immune responses
Yamanishi, Y., Miyake, K., Iki, M., Tsutsui, H., & Karasuyama, H. (2017) · Immunological Reviews · doi:10.1111/imr.12548 · Cited by 70
Selegiline and oxidative stress in HIV-associated cognitive impairment
Schifitto, G., Yiannoutsos, C. T., Ernst, T., NAVIA, B. A., Nath, A., Sacktor, N. C., Anderson, C., Marra, C. M., & Clifford, D. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c51a48 · Cited by 69
Gelman, B. B., Spencer, J. A., Holzer, C. E., & Soukup, V. M. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9030-6 · Cited by 69
Moreno, E., Moreno‐Delgado, D., Navarro, G., Hoffmann, H. M., Fuentes, S., Rosell-Vilar, S., Gasperini, P., Rodríguez-Ruiz, M., Medrano, M., Mallol, J., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4147-13.2014 · Cited by 69
Zhang, Y., Bi, X., Adebiyi, O., Wang, J., Mooshekhian, A., Cohen, J., Wei, Z., Wang, F., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00332 · Cited by 69
Kawano, M., Takagi, R., Kaneko, A., & Matsushita, S. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.001 · Cited by 68
Müller, S. C., März, R., Schmolz, M., Drewelow, B., Eschmann, K., & Meiser, P. (2012) · Phytotherapy Research · doi:10.1002/ptr.4678 · Cited by 68
Dopamine Receptors Modulate Cytotoxicity of Natural Killer Cells via cAMP-PKA-CREB Signaling Pathway
Zhao, W., Huang, Y., Liu, Z., Cao, B.-B., Peng, Y.-P., & Qiu, Y.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065860 · Cited by 68
Dopamine D2-like receptor signaling suppresses human osteoclastogenesis
Hanami, K., Nakano, K., Saito, K., Okada, Y., Yamaoka, K., Kubo, S., Kondo, M., & Tanaka, Y. (2013) · Bone · doi:10.1016/j.bone.2013.04.019 · Cited by 68
Aronow, W. S. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.05.009 · Cited by 68
Yang, Y., Cuevas, S., Yang, S., Villar, V. A. M., Escano, C. S., Asico, L. D., Yu, P., Jiang, X., Weinman, E. J., Armando, I., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03840 · Cited by 68
The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era
Chilunda, V., Calderon, T. M., Martínez-Aguado, P., & Berman, J. W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146426 · Cited by 68
Psychodermatological mechanisms of psoriasis
Torales, J. C., Echeverria, C. M., Barrios, I., García, Ó., O’Higgins, M. G., Castaldelli-Maia, J. M., Ventriglio, A., & Jafferany, M. (2020) · Dermatologic Therapy · doi:10.1111/dth.13827 · Cited by 68
Koblan, K. S., Hopkins, S. C., Sarma, K., Jin, F., GOLDMAN, R. S., Kollins, S. H., & Loebel, A. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.124 · Cited by 67
Chen, M., Tsai, T., Wang, L., Lin, Y.-Y., Tsai, Y.-M., Lee, M.-C., & Tsai, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.11.011 · Cited by 67
Shin, W.-H., Jeon, M., Leem, E., Won, S.-Y., Jeong, K. H., Park, S., McLean, C., Lee, S. J., Jin, B. K., Jung, U. J., et al. (2015) · Scientific Reports · doi:10.1038/srep14764 · Cited by 67
DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization
Liu, L., Wu, Y., Wang, B., Jiang, Y., Lin, L., Li, X., & Yang, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03778-6 · Cited by 67
Norepinephrine and dopamine increase motility, biofilm formation, and virulence of Vibrio harveyi
Yang, Q., Anh, N. D. Q., Bossier, P., & Defoirdt, T. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00584 · Cited by 66
Prevalence and risk factors of osteoporosis in patients with Parkinson’s disease
Bezza, A., Ouzzif, Z., Naji, H., Achemlal, L., Mounach, A., Nouijai, M., Bourazza, A., Mossadeq, R., & Maghraoui, A. E. (2008) · Rheumatology International · doi:10.1007/s00296-008-0632-6 · Cited by 66
la Cour, C. M., Salles, M., Pasteau, V., & Millan, M. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065409 · Cited by 66
Borroto‐Escuela, D. O., de la Mora, M. P., Manger, P. R., Narváez, M., Beggiato, S., Crespo‐Ramírez, M., Navarro, G., Wydra, K., Díaz-Cabiale, Z., Rivera, A., et al. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00020 · Cited by 66
Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease
Tolstanova, G. M., Deng, X., Ahluwalia, A., Paunovic, B., Prysiazhniuk, A., Остапченко, Л. І., Tarnawski, A. S., Sandor, Z., & Szabó, S. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3698-5 · Cited by 65
Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo.
Tarazona, R., González-Garcı́a, A., Zamzami, N., Marchetti, P., Frechin, N., Gonzalo, J. A., Ruiz‐Gayo, M., van Rooijen, N., Martinez, C., & Kroemer, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.861 · Cited by 65
A comparative fractal analysis of various mammalian astroglial cell types
Reichenbach, A., Siegel, A., Senitz, D., & Smith, T. G. (1992) · NeuroImage · doi:10.1016/1053-8119(92)90008-b · Cited by 65
Perreault, M. L., Jones-Tabah, J., O’Dowd, B. F., & George, S. R. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000685 · Cited by 65
Ariffin, J. K., & Sweet, M. J. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.002 · Cited by 65
Sonntag, K. C., Brenhouse, H. C., Freund, N., Thompson, B. S., Puhl, M., & Andersen, S. L. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3399-8 · Cited by 64
Glutamatergic control over brain dopamine release in vivo and in vitro
Whitton, P. S. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00034-6 · Cited by 64
Cosentino, M., Rasini, E., Colombo, C., Marino, F., Blandini, F., Ferrari, M., Samuele, A., Lecchini, S., Nappi, G., & Frigo, G. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.065 · Cited by 64
Ming, Y., Zhang, H., Long, L., Wang, F., Chen, J., & Zhen, X. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03961.x · Cited by 64
Catecholamines in murine bone marrow derived mast cells
Freeman, J. G., Ryan, J. J., Shelburne, C. P., Bailey, D. P., Bouton, L. A., Narasimhachari, N., Domen, J., Siméon, N., Couderc, F., & Stewart, J. K. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00384-8 · Cited by 64
Catecholamines inhibit microglial nitric oxide production
Chang, J. Y., & Liu, L.-Z. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00291-4 · Cited by 64
Expression of the D2 subfamily of dopamine receptor genes in kidney
Gao, D. Q., Canessa, L. M., Mouradian, M. M., & José, P. A. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.4.f646 · Cited by 64
Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays
Kirillova, G. P., Hrutkay, R. J., Shurin, M. R., Shurin, G. V., Tourkova, I. L., & Vanyukov, M. M. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.07.018 · Cited by 63
Kavelaars, A., Cobelens, P. M., Teunis, M., & Heijnen, C. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.004 · Cited by 63
Boneberg, E., von Seydlitz, E., Pröpster, K., Watzl, H., Rockstroh, B. S., & Illges, H. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.018 · Cited by 63
Sugama, S., Wirz, S., Barr, A. M., Conti, B., Bartfai, T., & Shibasaki, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.020 · Cited by 63
Reactive Oxygen Species–Dependent Hypertension in Dopamine D 2 Receptor–Deficient Mice
Armando, I., Wang, X., Villar, V. A. M., Jones, J. E., Asico, L. D., Escano, C. S., & José, P. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000254486.00883.3d · Cited by 63
Calderon, T. M., Williams, D. W., Lopez, L., Eugenín, E. A., Cheney, L., Gaskill, P. J., Veenstra, M., Anastos, K., Morgello, S., & Berman, J. W. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9726-9 · Cited by 63
Self-citationSystemic inflammation enhances stimulant-induced striatal dopamine elevation
Petrulli, J. R., Kalish, B., Nabulsi, N., Huang, Y. H., Hannestad, J. O., & Morris, E. D. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.18 · Cited by 63
T cells establish and maintain CNS viral infection in HIV-infected humanized mice
Honeycutt, J. B., Liao, B., Nixon, C. C., Cleary, R. A., Thayer, W. O., Birath, S., Swanson, M. D., Sheridan, P. A., Zakharova, O. I., Prince, F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98968 · Cited by 63
Leukocyte trafficking mechanisms in epilepsy
Fabene, P. F., Laudanna, C., & Constantin, G. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.009 · Cited by 62
Pivac, N., Knežević, J., Kozarić‐Kovačić, D., Deželjin, M., Mustapić, M., Rak, D., Glavan, T. M., Pavelić, J., & Mück‐Šeler, D. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.017 · Cited by 62
Should we be cautious on the use of commercially available antibodies to dopamine receptors?
Bodei, S., Arrighi, N., Spano, P., & Sigala, S. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0384-6 · Cited by 62
Cosentino, M., Zaffaroni, M., Ferrari, M., Marino, F., Bombelli, R., Rasini, E., Frigo, G., Ghezzi, A., Comı, G., & Lecchini, S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.019 · Cited by 62
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., & Gaskill, P. J. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100030 · Cited by 62
Self-citationOhta, K., Kuno, S., Mizuta, I., Fujinami, A., Matsui, H., & Ohta, M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00321-7 · Cited by 61
Peripheral dopamine in pathophysiology of hypertension. Interaction with aging and lifestyle.
Kuchel, O., & Kuchel, G. A. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.709 · Cited by 61
Najera, J. A., Bustamante, E., Bortell, N., Morsey, B., Fox, H. S., Ravasi, T., & Marcondes, M. C. G. (2016) · BMC Immunology · doi:10.1186/s12865-016-0145-0 · Cited by 61
Elgueta, D., Contreras, F., Prado, C. E., Montoya, A., Ugalde, V., Chovar, O., Villagra, R., Henríquez, C., Abellanas, M. A., Aymerich, M. S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00981 · Cited by 61
Liu, L., Jia, F., Yuan, G., Chen, Z., Yao, J., Li, H., & Fang, C. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.024 · Cited by 60
Cosentino, M., Marino, F., Bombelli, R., Ferrari, M., Rasini, E., Lecchini, S., & Frigo, G. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00019-x · Cited by 60
Multimorbidity, age-related comorbidities and mortality
Duffau, P., Ozanne, A., Bonnet, F., Lazaro, E., Cazanave, C., Blanco, P., Rivière, É., Desclaux, A., Hyernard, C., Gensous, N., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001875 · Cited by 60
Increased circulating regulatory T cells in medicated people with schizophrenia
Kelly, D. L., Li, X., Kilday, C., Feldman, S. M., Clark, S. M., Liu, F., Buchanan, R. W., & Tonelli, L. H. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.006 · Cited by 60
Nolan, R. A., Muir, R., Runner, K., Haddad, E. K., & Gaskill, P. J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9825-2 · Cited by 60
Self-citationDopamine promotes colonic mucus secretion through dopamine D 5 receptor in rats
Li, Y., Zhang, Y., Zhang, X., Feng, X., Liu, C., Zhang, X.-N., Quan, Z., Yan, J., & Zhu, J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00261.2017 · Cited by 60
Dopamine suppresses osteoclast differentiation via cAMP/PKA/CREB pathway
Wang, L., Han, L., Xue, P., Hu, X., Wong, S., Deng, M., Tseng, H. C., Huang, B., & Ko, C. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109847 · Cited by 60
Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications
Olivares-Hernández, A., Figuero-Pérez, L., Cruz, J. J., González‐Sarmiento, R., Usategui‐Martín, R., & Miramontes‐González, J. P. (2021) · Biomolecules · doi:10.3390/biom11020254 · Cited by 60
Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor[ndash ]independent mechanism
Sookhai, S., Wang, J. H., McCourt, M., O’Connell, D. P., & Redmond, H. P. (1999) · Surgery · doi:10.1016/s0039-6060(99)70171-6 · Cited by 59
Strell, C., Sievers, A., Bastian, P., Lang, K., Niggemann, B., Zänker, K. S., & Entschladen, F. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-62 · Cited by 59
The Epileptic Encephalopathies of Infancy and Childhood
Wirrell, E. C., Farrell, K., & Whiting, S. E. (2005) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100004388 · Cited by 59
Mechanism for the gastrokinetic action of domperidone
Takahashi, T., Kurosawa, S., Wiley, J. W., & Owyang, C. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90528-s · Cited by 59
Brain Structural Changes following HIV Infection: Meta-Analysis
O'Connor, E. E., Zeffiro, T., & Zeffiro, T. A. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5432 · Cited by 59
Transgenerational modification of dopaminergic dysfunctions induced by maternal immune activation
Weber‐Stadlbauer, U., Richetto, J., Zwamborn, R. A. J., Slieker, R. C., & Meyer, U. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00855-w · Cited by 59
Ou, Z., Zhou, Y., Wang, L., Xue, L., Zheng, J., Chen, L., & Tong, Q. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02198-5 · Cited by 59
Gisslén, M., Keating, S. M., Spudich, S., Arechiga, V. M., Stephenson, S., Zetterberg, H., Germanio, C. D., Blennow, K., Fuchs, D., Hagberg, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250987 · Cited by 59
Rocca, P., Leo, C. D., Eva, C. E., Marchiaro, L., Milani, A. M., Musso, R., Ravizza, L., Zanalda, E., & Bogetto, F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00253-1 · Cited by 58
Cyclooxygenase-2 Is an Obligatory Factor in Methamphetamine-Induced Neurotoxicity
Thomas, D. M., & Kuhn, D. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080242 · Cited by 58
Pantazopoulos, H., Stone, D., Walsh, J. P., & Benes, F. M. (2004) · Synapse · doi:10.1002/syn.20076 · Cited by 58
Bone, N. B., Liu, Z., Pittet, J., & Zmijewski, J. W. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0216-068rr · Cited by 58
Schier, C. J., Marks, W. D., Paris, J. J., Barbour, A. J., McLane, V. D., Maragos, W. F., McQuiston, A. R., Knapp, P. E., & Hauser, K. F. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0622-17.2017 · Cited by 58
Productive HIV infection in astrocytes can be established via a nonclassical mechanism
Li, G., Maric, D., Major, E. O., & Nath, A. (2020) · AIDS · doi:10.1097/qad.0000000000002512 · Cited by 58
A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor
Labouesse, M. A., & Patriarchi, T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00982-y · Cited by 58
Glucocorticoids and Inflammation: A Double-Headed Sword in Depression?
Horowitz, M. A., Zunszain, P. A., Anacker, C., Musaelyan, K., & Pariante, C. M. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343980 · Cited by 57
D1Dopamine Receptor Coupling to PLCβ Regulates Forward Locomotion in Mice
Medvedev, I. O., Ramsey, A. J., Masoud, S. T., Bermejo, M. K., Urs, N. M., Sotnikova, T. D., Beaulieu, J., Gainetdinov, R. R., & Salahpour, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2382-13.2013 · Cited by 57
Peters, J. L., & Michael, A. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741563.x · Cited by 57
Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson’s Disease
Manthripragada, A. D., Schernhammer, E. S., Qiu, J., Friis, S., Wermuth, L., Olsen, J. H., & Ritz, B. R. (2011) · Neuroepidemiology · doi:10.1159/000325653 · Cited by 57
Dopamine, T cells and multiple sclerosis (MS)
Levite, M., Marino, F., & Cosentino, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1640-4 · Cited by 57
Dagra, A., Miller, D. R., Lin, M., Gopinath, A., Shaerzadeh, F., Harris, S., Sorrentino, Z. A., Støier, J. F., Velasco, S., Azar, J., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00210-w · Cited by 57
Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01240-4 · Cited by 57
Serotonin Metabolism by Monoamine Oxidase in Rat Primary Astrocyte Cultures
Fitzgerald, L. W., Kaplinsky, L., & Kimelberg, H. K. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05789.x · Cited by 56
Fuziwara, S., Suzuki, A., Inoue, K., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23873.x · Cited by 56
Kazumori, H., Ishihara, S., Rumi, M. A. K., Ortega-Cava, C. F., Kadowaki, Y., & Kinoshita, Y. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00269.2003 · Cited by 56
Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure
Konkalmatt, P. R., Asico, L. D., Zhang, Y., Yu, Y. W., Drachenberg, C., Zheng, X., Han, F., José, P. A., & Armando, I. (2016) · JCI Insight · doi:10.1172/jci.insight.85888 · Cited by 56
Dopamine Produced by the Stomach May Act as a Paracrine/ Autocrine Hormone in the Rat
Mezey, É., Eisenhofer, G., Hansson, S. R., Hunyady, B., & Hoffman, B. J. (1998) · Neuroendocrinology · doi:10.1159/000054332 · Cited by 55
Dopamine Agonists Upregulate IL-6 and IL-8 Production in Human Keratinocytes
Parrado, A. C., Canellada, A. M., Gentile, T., & Rey-Roldán, E. B. (2012) · NeuroImmunoModulation · doi:10.1159/000342140 · Cited by 55
Dopamine Release in the Prefrontal Cortex and Striatum: Temporal and Behavioural Aspects
Hauber, W. (2010) · Pharmacopsychiatry · doi:10.1055/s-0030-1248300 · Cited by 55
Marzo, V. D., Vial, D., Sokoloff, P., Schwartz, J., & Piomelli, D. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-11-04846.1993 · Cited by 55
The effect of dopamine agonists: The expression of GDNF, NGF, and BDNF in cultured mouse astrocytes
Ohta, K., Kuno, S., Inoue, S., Ikeda, E., Fujinami, A., & Ohta, M. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.013 · Cited by 55
Pedrosa, R., José, P. A., & Soares-da-Silva, P. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00433.2003 · Cited by 55
Ginsberg, L. D., Oubré, A., & Daoud, Y. (2011) · PubMed · Cited by 55
SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder
Maron, E., Kuikka, J. T., Ulst, K., Tiihonen, J., Vasar, V., & Shlik, J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0520-3 · Cited by 54
Effect of dopamine on immune cell proliferation in mice
Tsao, C.-W., Lin, Y., & Cheng, J. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00962-4 · Cited by 54
Sookhai, S., Wang, J. H., Winter, D. C., Power, C. P., Kirwan, W. O., & Redmond, P. H. (2000) · Shock · doi:10.1097/00024382-200014030-00009 · Cited by 54
Pharmacological characterization of dopamine transport in cultured rat astrocytes
Inazu, M., Kubota, N., Takeda, H., Zhang, J., Kiuchi, Y., Oguchi, K., & Matsumiya, T. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00175-7 · Cited by 54
Homeostatic regulation of glutamatergic transmission by dopamine D 4 receptors
Yuen, E. Y., Zhong, P., & Yan, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010025108 · Cited by 54
The neurotransmitter dopamine modulates vascular permeability in the endothelium
Bhattacharya, R., Sinha, S., Yang, S.-P., Patra, C. R., Dutta, S. K., Wang, E., & Mukhopadhyay, D. (2008) · Journal of Molecular Signaling · doi:10.1186/1750-2187-3-14 · Cited by 54
Inflammatory Processes, Febrile Seizures, and Subsequent Epileptogenesis
Choy, M., Dubé, C. M., Ehrengruber, M. U., & Baram, T. Z. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-14.s2.15 · Cited by 54
Vasopressor and Inotropic Management Of Patients With Septic Shock.
Pollard, S. R., Edwin, S. B., & Alaniz, C. (2015) · PubMed · Cited by 54
Vyas, S. J., Eichberg, J., & Lokhandwala, M. F. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11200-7 · Cited by 54
Mast Cells in Human Health and Disease
DeBruin, E., Gold, M., Lo, B. C., Snyder, K., Cait, A., Lasic, N., Lopez, M., McNagny, K. M., & Hughes, M. R. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1568-2_7 · Cited by 54
Dopamine regulates cytokine secretion during innate and adaptive immune responses
Kawano, M., Takagi, R., Saika, K., Matsui, M., & Matsushita, S. (2018) · International Immunology · doi:10.1093/intimm/dxy057 · Cited by 54
Yang, Y., Zhang, Y., Cuevas, S., Villar, V. A. M., Escano, C. S., Asico, L. D., Yu, P., Grandy, D. K., Felder, R. A., Armando, I., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.015 · Cited by 53
Magro, F., Fraga, S., Ribeiro, T., et al. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01260.x · Cited by 53
Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease
Knott, C., Wilkin, G. P., & Stern, G. M. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00022-x · Cited by 53
The role of catecholamines in HIV neuropathogenesis
Nolan, R. A., & Gaskill, P. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.030 · Cited by 53
Self-citationBananej, M., Karimi-Sori, A., Zarrindast, M. R., & Ahmadi, S. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111405556 · Cited by 52
Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats
Wahba, M. G. F., Messiha, B. A. S., & Abo‐Saif, A. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.026 · Cited by 52
Toti, L., & Travagli, R. A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00258.2014 · Cited by 52
Zhang, X., Zhou, Z., Wang, D., Li, A., Yin, Y., Gu, X., Ding, F., Zhen, X., & Zhou, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0389-09.2009 · Cited by 52
Demane, D. F., Contreras, F., González, H., Prado, C. E., Elgueta, D., Figueroa, C. A., & Pacheco, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.003 · Cited by 52
D 3 dopamine receptor-preferring [ 11 C]PHNO PET imaging in Parkinson patients with dyskinesia
Payer, D. E., Guttman, M., Kish, S. J., Tong, J., Adams, J. R., Rusjan, P., Houle, S., Furukawa, Y., Wilson, A. A., & Boileau, I. (2015) · Neurology · doi:10.1212/wnl.0000000000002285 · Cited by 52
Cross interaction of dopaminergic and adrenergic systems in neural modulation.
Lei, S. (2014) · Europe PMC (PubMed Central) · Cited by 51
Chronic 5-HT Transporter Blockade Reduces DA Signaling to Elicit Basal Ganglia Dysfunction
Morelli, E., Moore, H. M., Rebello, T. J., Gray, N., Steele, K. N., Esposito, E., Gingrich, J. A., & Ansorge, M. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2989-11.2011 · Cited by 51
Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers
Borroto‐Escuela, D. O., Ravani, A., Tarakanov, A. O., Brito, I., Narváez, M., Romero‐Fernandez, W., Corrales, F., Agnati, L. F., Tanganelli, S., Ferraro, L., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.058 · Cited by 51
Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs
Czub, S., Czub, M., Koutsilieri, E., Sopper, S., Villinger, F. J., Müller, J. G., Stahl‐Hennig, C., Riederer, P. F., ter Meulen, V., & Gosztonyi, G. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0801-3 · Cited by 51
Mori, T., Kabashima, K., Fukamachi, S., Kuroda, E., Sakabe, J., Kobayashi, M., Nakajima, S., Nakano, K., Tanaka, Y., Matsushita, S., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.03.008 · Cited by 51
A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
Lamos, E. M., Levitt, D. L., & Munir, K. M. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.10.008 · Cited by 51
Handa, K., Kiyohara, S., Yamakawa, T., Ishikawa, K., Hosonuma, M., Sakai, N., Karakawa, A., Chatani, M., Tsuji, M., Inagaki, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50336-4 · Cited by 51
Wang, C., Ge, X., Wang, M., Ma, T., Zhang, Y., & Lin, Y. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1529-x · Cited by 51
Liu, J., Wang, F., Huang, C., Long, L., Wu, W., Cai, F., Wang, J., Ma, L., & Chen, J. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9323-9 · Cited by 50
Nitric Oxide Donors Enhance the Frequency Dependence of Dopamine Release in Nucleus Accumbens
Hartung, H., Threlfell, S., & Cragg, S. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.62 · Cited by 50
The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder
Moreira, R. (2011) · Clinical Drug Investigation · doi:10.2165/1159616-s0-000000000-00000 · Cited by 50
Liu, L., Yuan, G., Cheng, Z., Zhang, G., Liu, X., & Zhang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075259 · Cited by 50
Leung, J., Peacock, A., Colledge‐Frisby, S., Grebely, J., Cunningham, E. B., Hickman, M., Vickerman, P. T., Stone, J., Trickey, A., Dumchev, K. V., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz058 · Cited by 50
Capellino, S., Cosentino, M., Luini, A., Bombelli, R., Lowin, T., Cutolo, M., Marino, F., & Straub, R. H. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38746 · Cited by 49
Enzymatic deconjugation of catecholamines in human and rat plasma and red blood cell lysate
Yoneda, S., Alexander, N., & Vlachakis, N. D. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90749-x · Cited by 49
Giana, G., Romano, E., Porfirio, M. C., D’Ambrosio, R., Giovinazzo, S., Troianiello, M., Barlocci, E., Travaglini, D., Granstrem, O., Pascale, E., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.008 · Cited by 49
Missale, C., Castelletti, L., Memo, M., Carruba, M. O., & Spano, P. (1988) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198806000-00003 · Cited by 49
Brendel, M., Focke, C., Blume, T., Peters, F., Deußing, M., Probst, F., Jaworska, A. M., Overhoff, F., Albert, N. L., Lindner, S., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195107 · Cited by 49
Sun, Y., Pham, A. N., Hare, D. J., & Waite, T. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00859 · Cited by 49
Hammer, G. B., Verghese, S. T., Drover, D. R., Yaster, M., & Tobin, J. R. (2008) · BMC Anesthesiology · doi:10.1186/1471-2253-8-6 · Cited by 48
Plasma dopamine and noradrenaline variations in response to stress
LEBLANC, J., & Ducharme, M. B. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.02.011 · Cited by 48
Haskó, G., Szabó, C., Merkel, K., Bencsics, A., Zingareli, B., Kvetan, V., & Vizi, E. S. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02494-7 · Cited by 48
Autoradiographic Localization of Vascular Dopamine Receptors
Amenta, F., Collier, W. L., & Rícci, A. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.6.34s · Cited by 48
Motyl, K. J., Beauchemin, M., Barlow, D. J., Le, P. T., Nagano, K., Treyball, A., Contractor, A., Baron, R., Rosen, C. J., & Houseknecht, K. L. (2017) · Bone · doi:10.1016/j.bone.2017.07.008 · Cited by 48
Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension
Yang, J., Villar, V. A. M., José, P. A., & Zeng, C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8106 · Cited by 48
Salmeron, P. A. (2009) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2009.00438.x · Cited by 47
Dopamine action and metabolism in the kidney
Aperia, A. (1994) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199401000-00005 · Cited by 47
Catecholamine Glucuronidation: An Important Metabolic Pathway for Dopamine in the Rat
Wang, P., Kuchel, O., Buu, N. T., & Genest, J. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb13587.x · Cited by 47
Wigal, S. B., Wigal, T. L., Hobart, M., Madera‐McDonough, J., Baker, R. A., Kohegyi, E., McKinney, A. A., & Wilens, T. E. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s242084 · Cited by 47
Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang, Y., Qiu, A.-W., Peng, Y.-P., Liu, Y., Huang, H., & Qiu, Y. (2010) · PubMed · Cited by 46
Roesler, R., Dini, S. A., & Isolan, G. R. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13668 · Cited by 46
Hjorth, O. R., Frick, A., Gingnell, M., Hoppe, J. M., Faria, V., Hultberg, S., Alaie, I., Månsson, K. N. T., Rosén, J., Reis, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01682-3 · Cited by 46
Postmortem Stability of Monoamines, Their Metabolites, and Receptor Binding in Rat Brain Regibns
Kontur, P. J., Al‐Tikriti, M. S., Innis, R. B., & Roth, R. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010282.x · Cited by 45
Sawada, H., Hishida, R., Hirata, Y., Ono, K., Suzuki, H., Muramatsu, S., Nakano, I., Nagatsu, T., & Sawada, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21241 · Cited by 45
Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms
Glover, D. A., Powers, M. B., Bergman, L., Smits, J. A. J., Telch, M. J., & Stuber, M. L. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00074-3 · Cited by 45
Ambrosi, G., Kuštrimović, N. Z., Siani, F., Rasini, E., Cerri, S., Ghezzi, C., Dicorato, G., Caputo, S., Marino, F., Cosentino, M., et al. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9712-2 · Cited by 45
Pharmacotherapy in patients with epilepsy and psychosis
de Toffol, B., Trimble, M., Hesdorffer, D. C., Taylor, L., Sachdev, P. S., Clancy, M., Adachi, N., Bragatti, J. A., Mula, M., & Kanemoto, K. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.09.001 · Cited by 45
Bipolar disorder: clinical overview.
Jk, M., & Leweke, F. M. (2016) · PubMed · Cited by 45
Yoshioka, Y., Sugino, Y., Shibagaki, F., Yamamuro, A., Ishimaru, Y., & Maeda, S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172826 · Cited by 45
Zhen, X., Zhang, J., Johnson, G. P., & Friedman, E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12314-0 · Cited by 45
Zarinara, A., Mohammadi, M., Hazrati, N., Tabrizi, M., Rezazadeh, S., Rezaie, F., & Akhondzadeh, S. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1148 · Cited by 44
Non-neuronal dopamine in the gastrointestinal system.
Mezey, É., Eisenhofer, G., Hansson, S. R., Harta, G., Hoffman, B. J., Gallatz, K., Palkovits, M., & Hunyady, B. (1999) · PubMed · Cited by 43
Zhen, X., Zhang, J., Johnson, G., & Friedman, E. (2001) · PubMed · Cited by 43
O'Sullivan, G. J., Dunleavy, M., Håkansson, K., Clementi, M., Kinsella, A., Croke, D. T., Drago, J., Fienberg, A. A., Greengard, P., Sibley, D. R., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.011 · Cited by 43
Sidharthan, N. P., Minchin, R. F., & Butcher, N. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493239 · Cited by 43
Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes
Κοκκίνου, Ι., Nikolouzou, E., Hatzimanolis, A., Fragoulis, E. G., & Vassilacopoulou, D. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.10.010 · Cited by 43
Li, H., Han, W., Villar, V. A. M., Keever, L. B., Lu, Q., Hopfer, U., Quinn, M. T., Felder, R. A., José, P. A., & Yu, P. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.120642 · Cited by 43
Bab, I., & Yirmiya, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05218.x · Cited by 43
Waes, V. V., Beverley, J. A., Marinelli, M., & Steiner, H. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07294.x · Cited by 43
Prado, C., Gaiazzi, M., González, H., Ugalde, V., Figueroa, A., Osorio-Barrios, F. J., López, E., Lladser, A., Rasini, E., Marino, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00571 · Cited by 43
Bauman, M. D., Lesh, T. A., Rowland, D. J., Schumann, C. M., Smucny, J., Kukis, D. L., Cherry, S. R., McAllister, A. K., & Carter, C. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0449-y · Cited by 43
Jafarinia, M., Mohammadi, M., Modabbernia, A., Ashrafi, M., Khajavi, D., Tabrizi, M., Yadegari, N., & Akhondzadeh, S. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2242 · Cited by 42
Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling
Erami, C., Zhang, H., Tanoue, A., Tsujimoto, G., THOMAS, S. A., & Faber, J. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00129.2005 · Cited by 42
Fang, Y., Thomas, G. N., Xu, Z., Fang, J., Critchley, J., & Tomlinson, B. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.010 · Cited by 42
Magro, F., Cunha, E., Araújo, F., Meireles, E., Pereira, P., Dinis-Ribeiro, M. J., Veloso, F. T., Medeiros, R., & Soares-da-Silva, P. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9168-3 · Cited by 42
The meningeal lymphatic system: a route for HIV brain migration?
Lamers, S. L., Rose, R., Ndhlovu, L. C., Nolan, D. J., Salemi, M., Maidji, E., Stoddart, C. A., & McGrath, M. S. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0399-y · Cited by 42
Wu, S., Xu, G., STANLEY, D. W., Huang, J., & Yè, G. (2015) · Scientific Reports · doi:10.1038/srep12247 · Cited by 42
Lan, Y., Wang, X., Xing, J., Yu, Z., Lou, J., Ma, X., & Zhang, B. (2017) · Oncotarget · doi:10.18632/oncotarget.19691 · Cited by 42
Hsu, D. C., Sunyakumthorn, P., Wegner, M. D., Schuetz, A., Silsorn, D., Estes, J. D., Deléage, C., Tomusange, K., Lakhashe, S. K., Ruprecht, R. M., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00222-18 · Cited by 42
HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System
Nickoloff-Bybel, E. A., Calderon, T. M., Gaskill, P. J., & Berman, J. W. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09927-6 · Cited by 42
Self-citationGangarossa, G., Ceolin, L., Paucard, A., Lerner‐Natoli, M., Perroy, J., Fagni, L., & Valjent, E. (2014) · Hippocampus · doi:10.1002/hipo.22327 · Cited by 41
Jiang, X., Konkalmatt, P. R., Yu, Y. W., Gildea, J. J., Jones, J. E., Cuevas, S., Felder, R. A., José, P. A., & Armando, I. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02569 · Cited by 41
Yoon, S., & Baik, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.461202 · Cited by 41
Sheu, J., Wang, K.-H., Lin, H., & Huang, C. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.12.961 · Cited by 41
Chaves, C., Marque, C. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., Ferrari, T. B., Santos, A. C., Araújo, D., Machado-de-Sousa, J. P., Bressan, R. A., Elkis, H., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.031 · Cited by 41
Merlini, E., Tincati, C., Biasin, M., Saulle, I., Cazzaniga, F. A., Monforte, A. D., Cappione, A., Snyder-Cappione, J. E., Clerici, M., & Marchetti, G. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00614 · Cited by 41
Targeting dopamine receptor D3 signalling in inflammation
Pacheco, R. (2017) · Oncotarget · doi:10.18632/oncotarget.14601 · Cited by 41
Kang, Y., Mozley, P. D., Verma, A. K., Schlyer, D. J., Henchcliffe, C., Gauthier, S. A., Chiao, P., He, B., Nikolopoulou, A., Logan, J., et al. (2018) · Journal of Neuroimaging · doi:10.1111/jon.12519 · Cited by 41
Osorio-Barrios, F., Prado, C., Contreras, F., & Pacheco, R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00192 · Cited by 41
Niu, M., Morsey, B., Lamberty, B. G., Emanuel, K. M., Yu, F., León‐Rivera, R., Berman, J. W., Gaskill, P. J., Matt, S. M., Ciborowski, P. S., et al. (2020) · Viruses · doi:10.3390/v12111297 · Cited by 41
Self-citationLiu, Z., Zhai, X.-R., Du, Z.-S., Xu, F.-F., Huang, Y., Wang, X., Qiu, Y., & Peng, Y.-P. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.220 · Cited by 41
Zhu, J., Feng, C., Zhang, W., Wang, Z., Zhong, M., Wang, Z., Wang, Z., Shi, H., Yin, Z., Shi, J., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00453-0 · Cited by 41
Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder
Ferreira, T. B., Kasahara, T. M., Barros, P. O., Vieira, M. M. M., Bittencourt, V. C. B., Hygino, J., Andrade, R. M., Linhares, U. C., Andrade, A. F., & Bento, C. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.009 · Cited by 40
Undie, A. S., & Friedman, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63010222.x · Cited by 40
Each Individual Isoform of the Dopamine D2 Receptor Protects from Lactotroph Hyperplasia
Radl, D. B., Mei, C. D., Chen, E., Lee, H., & Borrelli, E. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1008 · Cited by 40
Yao, Y., Schröder, J., & Karlsson, H. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.011 · Cited by 40
HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Fitting, S., Booze, R. M., & Mactutus, C. F. (2015) · Current HIV Research · doi:10.2174/1570162x13666150121110731 · Cited by 40
Cited by
Uncovering the metabolic impact of acute psychological stress in young adults
Frempong, G. A., Goni, G., Lorenzo-Tejedor, M., De la Cámara, C., Lázaro, J., Mangialavori Rasia, E., Aguiló, J., Bailon, R., & Bernal, M. L. (2026) · Scientific Reports · doi:10.1038/s41598-025-29572-4 · Cited by 3
Metadata
- Authors
- Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 75
- Issue
- 1
- Pages
- 62-158
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4311937162
- Cited by
- 308
- References
- 1,227
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.